Eric Lefkofsky seems to be an expert in the Tempus Chicago lab. Tempus is a medical startup that he started. While he is showing off slides of breast cancer, the lab is combining artificial intelligence and health care. He is 49 years old and has launched five companies for roughly $250 million each. He is worth $2.7 billion.
All of Eric Lefkofsky’s ventures are based on data improving the industries they are in. Tempus is no different and will allow doctors to create a more effective, personalized cancer treatment. Using the genomic sequencer Tempus can identify mutations in the epidermal growth factor gene. There are 700 employees of Tempus and after Eric Lefkofsky’s $100 million they raised another $420 million for cancer treatments. He expects the company to expand into chronic conditions next. The sequencing costs at Tempus run $1,000 to $5,000 per user. The company loses money from this, but they also license a library of insurers, researchers and drug companies.
In 2001, Eric Lefkofsky co-founded a marketing company called InnerWorkings, a transportation company called Echo Global Logistics and an advertising software company called Mediaocean. One person he hired had an idea for a company and he invested $1 million. It became Groupon. He helped a few other companies during this time. In 2014, his wife was diagnosed with breast cancer. Not understanding the lack of data from her doctors he started Tempus. Even with top data, the competition is fierce. Though he was sent fewer samples than other companies, people were surprised with the data Tempus sent back. Find out more about Eric Lefkofsky: https://www.cancer.northwestern.edu/research/funding-opportunities/lefkofsky.html